Embracer Group (EMBRAC) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
14 Jan, 2026Executive summary
Net sales for Q2 FY 2024/25 were SEK 8,552 million, representing a 14% organic decline and a 21% year-over-year drop, mainly due to fewer major releases and divestments.
Adjusted EBIT was SEK 1,207 million, down 21% year-over-year, with free cash flow negative at SEK -473 million, mainly from inventory buildup.
The divestment of Easybrain for USD 1.2 billion (EUR 1.2 billion/SEK 12.9 billion) was announced, expected to close in early 2025, significantly improving the financial position and resetting net debt.
Asmodee delivered solid earnings growth and is preparing for a public listing, with a Capital Markets Day scheduled for November 19.
Ongoing efficiency improvements and ROI focus across segments.
Financial highlights
Net sales: SEK 8,552 million in Q2 FY 2024/25, down from SEK 9,569 million year-over-year.
Adjusted EBIT: SEK 1,207 million, margin 14%, down 21% year-over-year.
Free cash flow after working capital: SEK -473 million, down from SEK 387 million last year.
Net debt at SEK 13.2 billion as of September 30, 2024, with pro forma net debt expected to be near zero or SEK 0.5 billion post-Easybrain sale.
Basic EPS was SEK -0.32, adjusted EPS SEK 0.18.
Outlook and guidance
Lower earnings expected for PC/Console segment this year due to project delays and softer performance.
Asmodee's peak sales and cash generation are expected in Q3 and Q4 due to seasonality.
Asmodee spin-off on track for FY 2024/25 listing, with further details at the November 19 Capital Markets Day.
No formal guidance provided, but conservative outlook for PC/Console EBIT in Q3.
Key upcoming release: Kingdom Come: Deliverance II set for February 11, 2025.
Latest events from Embracer Group
- Q3 sales dropped 26% YoY, but core IPs outperformed and EBIT guidance is SEK 750 million.EMBRAC
Q3 25/2612 Feb 2026 - Lean teams, strong IPs, and SEK 500m net cash drive growth and shareholder returns.EMBRAC
Coffee Stain CMD 20253 Feb 2026 - Sales and EBIT dropped, but cash flow and debt improved as spin-off plans progressed.EMBRAC
Q1 24/251 Feb 2026 - All proposals passed as 12% sales growth and a split into three listed entities were announced.EMBRAC
AGM 202420 Jan 2026 - Aims for 18%+ EBITDA margin and global IP leadership, driven by growth and sustainability.EMBRAC
Asmodee CMD 202413 Jan 2026 - 7% organic growth, strong cash flow, and major spin-offs mark a transformative Q3.EMBRAC
Q3 24/2527 Dec 2025 - Net sales fell 31% year-over-year as the group shifts to core IPs and prepares a major spin-off.EMBRAC
Q1 25/2623 Nov 2025 - Q4 organic growth, strong cash, and Coffee Stain spin-off drive future AAA pipeline.EMBRAC
Q4 24/2519 Nov 2025 - Q2 sales fell 19% with EBIT at SEK 109 million; full-year profit guidance is maintained.EMBRAC
Q2 25/2613 Nov 2025